ReWalk Robotics’ (RWLK) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of ReWalk Robotics (NASDAQ:RWLK – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a $3.00 price objective on the medical device company’s stock. HC Wainwright also issued estimates for ReWalk Robotics’ Q4 2023 earnings at ($0.13) EPS, FY2023 […]

Leave a Reply

Your email address will not be published.

Previous post Benchmark Reaffirms “Buy” Rating for Tencent Music Entertainment Group (NYSE:TME)
Next post StockNews.com Begins Coverage on Symbolic Logic (NASDAQ:EVOL)